Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Enliven Therapeutics Inc., 3 years.
Enliven Therapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Enliven Therapeutics Inc. June 18, 202495.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 4, 2026 | Enliven Therapeutics Inc. | Option exercise | +87,373 | $2.48 | $216,685 |
| Aug 4, 2026 | Enliven Therapeutics Inc. | Option exercise | +27,567 | $25.28 | $696,894 |
| Aug 4, 2026 | Enliven Therapeutics Inc. | Option exercise | +23,364 | $14.85 | $346,955 |
| Aug 4, 2026 | Enliven Therapeutics Inc. | Option exercise | +20,491 | $22.47 | $460,433 |
| Aug 4, 2026 | Enliven Therapeutics Inc. | Open-market sale | −158,795 | $60.21 | $9,561,587 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.